RCGP curriculum - Introducing the GP curriculum
Dr Ben Riley and Dr Jayne Haynes explain what the curriculum is and why it is necessary. Read more
Looking at studies from Europe and the US, the researchers found that life expectancy went from an average of 56.1 years in 1996-99, to 69.4 years in 2003-05.
Mortality rates for people on combination antiretroviral therapy also fell by 40 per cent over this period, according to the research published in The Lancet.
Improvements in long-term combination antiretroviral therapy are believed to be the main factor in this.
But despite the improvements, a HIV-negative person is likely to outlive one with HIV by 20 years.
In a second article in the journal, an Australian team criticises a statement made by the Swiss Federal Commission for HIV/AIDS earlier this year that HIV-positive patients on effective antiretroviral treatment cannot transmit HIV through sexual contact.
While the risk may be low, if people follow this advice and do not use condoms, the number of HIV infections could quadruple within 10 years, says the team led by Dr David Wilson from the University of New South Wales.
‘As a population strategy, treatment as prevention has the potential to reduce HIV epidemics only if consistent condom use is maintained,’ wrote the researchers.
rachel.liddle@haymarket.com
Lancet 2008; 372: 293-313
Comment below and tell us what you think
Dr Ben Riley and Dr Jayne Haynes explain what the curriculum is and why it is necessary. Read more
Greater awareness of drinking problems is needed, say Professor Eileen Kaner and Ruth McGovern. Read more
Dr Sathya Naidoo explains the criteria that are required for completing iMAP. Read more
Contributed by Dr Matthew Litchfield, GP, Nottingham and Dr James Milledge, retired consultant respi... Read more
Contributed by Mr David Walker, consultant obstetrician and gynaecologist at the Royal United Hospit... Read more
Contributed by Dr Unni Krishnan, clinical research fellow in cardiology at the Glenfield Hospital, L... Read more
GSK has launched Volibris (ambrisentan) for the treatment of pulmonary arterial hypertension (WHO Cl... Read more
Thymoglobuline is an immunosuppressant for the prophylaxis of graft rejection in renal or heart tra... Read more
Tyverb (lapatinib) is an oral antineoplastic agent that may provide women with an alternative option... Read more
Comments
Only registered users may comment. Log in now or register for a free account.